Adrenergic Antagonists Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Adrenergic Antagonists. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Adrenergic Antagonists Indian Medical PG Question 1: Effects of beta blockers on the heart are all of the following except:
- A. Decreases duration of systole (Correct Answer)
- B. Decrease in heart rate
- C. May decrease cardiac output initially.
- D. May precipitate heart failure in acute settings.
Adrenergic Antagonists Explanation: ***Decreases duration of systole***
- Beta-blockers primarily prolong the **duration of systole** by extending the **ejection time** and slowing ventricular relaxation.
- They also increase the **diastolic filling time** by reducing heart rate, impacting overall cardiac cycle duration.
*Decrease in heart rate*
- Beta-blockers block **beta-1 adrenergic receptors** in the heart, leading to a decrease in **sympathetic stimulation** and thus a reduced heart rate.
- This effect is beneficial in conditions like **tachycardia** and **angina**, as it reduces myocardial oxygen demand.
*May decrease cardiac output initially.*
- By reducing heart rate and contractility, beta-blockers can initially decrease **cardiac output**, especially in patients with pre-existing **ventricular dysfunction**.
- This effect is often transient, as chronic use can lead to beneficial remodeling and improved efficiency in some conditions.
*May precipitate heart failure in acute settings.*
- In patients with acutely decompensated heart failure or severe left ventricular dysfunction, beta-blockers can acutely worsen cardiac function due to their **negative inotropic effects**.
- Therefore, beta-blockers are typically initiated cautiously at low doses in stable heart failure patients and are contraindicated in acute decompensation.
Adrenergic Antagonists Indian Medical PG Question 2: Which of the following beta blockers is not considered cardioselective?
- A. Atenolol
- B. Esmolol
- C. Metoprolol
- D. Carvedilol (Correct Answer)
Adrenergic Antagonists Explanation: ***Carvedilol***
- **Carvedilol** is a **non-selective beta-blocker** and also possesses **alpha-1 adrenergic blocking activity**, differentiating it from cardioselective agents.
- Its mechanism of action involves blocking both **beta-1** and **beta-2 receptors**, as well as **alpha-1 receptors**, which contributes to its broader therapeutic uses, such as in heart failure.
*Metoprolol*
- **Metoprolol** is considered a **cardioselective (beta-1 selective) beta-blocker** at lower doses, primarily affecting the heart.
- It has a lower propensity to cause **bronchoconstriction** or affect peripheral circulation compared to non-selective agents.
*Atenolol*
- **Atenolol** is a **cardioselective beta-blocker** that preferentially blocks **beta-1 adrenergic receptors** in the heart.
- It is frequently used for conditions where specific **cardiac effects** are desired while minimizing impact on other systems.
*Esmolol*
- **Esmolol** is an **ultra-short-acting**, **cardioselective beta-blocker** that primarily blocks **beta-1 receptors**.
- Its rapid onset and short duration of action make it particularly useful in **acute care settings**, such as perioperative hypertension or supraventricular tachyarrhythmias.
Adrenergic Antagonists Indian Medical PG Question 3: A mixed α1 blocker and 5-HT1A receptor agonist, used as an antihypertensive agent, is which of the following?
- A. Trimazosin
- B. Tamsulosin
- C. Doxazosin
- D. Urapidil (Correct Answer)
Adrenergic Antagonists Explanation: ***Urapidil***
- **Urapidil** acts as a **mixed α1-blocker** and has an additional effect as a **5-HT1A receptor agonist**, which contributes to its antihypertensive properties beyond direct vasodilation.
- Its unique dual mechanism sets it apart from other alpha-blockers by also modulating serotonin pathways to reduce blood pressure.
*Trimazosin*
- **Trimazosin** is a **direct-acting peripheral vasodilator** primarily described as an **alpha-adrenergic blocker**, but it does not possess significant 5-HT1A receptor agonist activity.
- It is an older antihypertensive medication not commonly used today, with a primary mechanism focused solely on alpha-blocking.
*Tamsulosin*
- **Tamsulosin** is a **selective α1A-adrenergic receptor antagonist**, specifically used to treat **benign prostatic hyperplasia (BPH)** symptoms by relaxing smooth muscle in the prostate and bladder neck.
- It does not have significant 5-HT1A receptor agonist activity, and its primary use is not for general hypertension management.
*Doxazosin*
- **Doxazosin** is a **selective α1-adrenergic receptor antagonist** used to treat both **hypertension** and **benign prostatic hyperplasia (BPH)**.
- While it effectively blocks alpha-1 receptors to lower blood pressure, it does not exert significant agonistic effects on 5-HT1A receptors.
Adrenergic Antagonists Indian Medical PG Question 4: Which of the following is a second-generation beta blocker?
- A. Timolol
- B. Atenolol (Correct Answer)
- C. Nadolol
- D. Propranolol
Adrenergic Antagonists Explanation: ***Atenolol***
- **Atenolol** is a **second-generation beta blocker** characterized by its **cardioselectivity**, meaning it primarily blocks beta-1 receptors in the heart.
- This selectively reduces heart rate and contractility with fewer respiratory side effects compared to non-selective agents.
*Propranolol*
- **Propranolol** is a **first-generation non-selective beta blocker**, meaning it blocks both beta-1 and beta-2 adrenergic receptors.
- Its non-selective action can cause significant bronchoconstriction, making it less suitable for patients with respiratory conditions.
*Timolol*
- **Timolol** is also a **first-generation non-selective beta blocker** commonly used in ophthalmic preparations for glaucoma.
- It blocks both beta-1 and beta-2 receptors and does not possess the cardioselectivity of second-generation agents.
*Nadolol*
- **Nadolol** is another **first-generation non-selective beta blocker** with a long duration of action due to its extensive plasma half-life.
- Like other first-generation agents, it lacks cardioselectivity and blocks both beta-1 and beta-2 receptors.
Adrenergic Antagonists Indian Medical PG Question 5: Which of the following is false about pheochromocytoma?
- A. Surgery is the treatment of choice
- B. VMA (vanillylmandelic acid) is a diagnostic test
- C. Propranolol is the preferred drug for hypertension control (Correct Answer)
- D. Catecholamines are a diagnostic test
- E. Most pheochromocytomas are benign
Adrenergic Antagonists Explanation: ***Propranolol is the preferred drug for hypertension control***
- Propranolol, a **beta-blocker**, is generally contraindicated as monotherapy in pheochromocytoma because blocking beta-receptors unopposed can lead to a **hypertensive crisis** due to unopposed alpha-adrenergic vasoconstriction.
- **Alpha-blockers** (e.g., phenoxybenzamine) are the first-line agents for hypertension control, followed by beta-blockers once adequate alpha-blockade is established.
*Surgery is the treatment of choice*
- **Surgical resection** of the tumor is indeed the definitive treatment for pheochromocytoma once the patient has been appropriately prepared with alpha-blockade.
- This approach aims to remove the source of excessive catecholamine production and resolve the associated symptoms.
*VMA (vanillylmandelic acid) is a diagnostic test*
- **VMA** is a metabolic breakdown product of catecholamines, and its measurement in a **24-hour urine collection** is a long-standing method for diagnosing pheochromocytoma.
- Elevated VMA levels indicate overproduction of catecholamines, which is characteristic of the tumor.
*Catecholamines are a diagnostic test*
- Measuring **plasma free metanephrines** and **24-hour urinary fractionated metanephrines** (which are methylated metabolites of catecholamines) are highly sensitive and specific diagnostic tests for pheochromocytoma.
- Elevated levels confirm the excessive secretion of these hormones by the tumor.
*Most pheochromocytomas are benign*
- Approximately **90% of pheochromocytomas are benign**, with only about 10% being malignant.
- The **"rule of 10s"** is a helpful mnemonic: 10% bilateral, 10% extra-adrenal, 10% malignant, 10% familial, and 10% occur in children.
Adrenergic Antagonists Indian Medical PG Question 6: Which class of antihypertensive drugs is known to cause erectile dysfunction?
- A. Calcium channel blocker
- B. ACE inhibitors
- C. AT1 receptor antagonists
- D. Beta-blockers (Correct Answer)
Adrenergic Antagonists Explanation: ***Beta-blockers***
- **Beta-blockers** are the antihypertensive class most commonly associated with **erectile dysfunction**
- Mechanism: Reduced cardiac output, decreased peripheral blood flow, central nervous system effects reducing libido, and blockade of β2-mediated vasodilation
- **Non-selective beta-blockers** (propranolol, nadolol) have higher incidence of ED compared to selective β1-blockers (metoprolol, atenolol)
- Newer vasodilating beta-blockers (nebivolol, carvedilol) have lower risk of sexual dysfunction
*Calcium channel blockers*
- Generally have **neutral or minimal effect** on erectile function
- May even improve ED in some patients due to **vasodilatory properties**
- Side effects include peripheral edema and headache, but not sexual dysfunction
*ACE inhibitors*
- Associated with **lower risk of erectile dysfunction** compared to other antihypertensives
- May have neutral or even protective effects on sexual function
- Preferred choice for hypertensive patients with existing sexual dysfunction concerns
- Common side effects: dry cough and angioedema (not related to sexual function)
*AT1 receptor antagonists*
- **ARBs have neutral to potentially beneficial effects** on sexual function
- Considered an excellent alternative for patients experiencing sexual side effects with other antihypertensive medications
- Some studies suggest they may improve erectile function in hypertensive patients
Adrenergic Antagonists Indian Medical PG Question 7: Which of the following is not an alpha-blocker?
- A. Atenolol (Correct Answer)
- B. Indoramine
- C. Idazoxan
- D. Prazosin
Adrenergic Antagonists Explanation: ***Atenolol***
- Atenolol is a **selective beta-1 adrenergic receptor blocker**, primarily used to treat hypertension, angina, and certain arrhythmias.
- Its mechanism of action involves **blocking the effects of adrenaline** on the heart, leading to decreased heart rate and blood pressure, rather than affecting alpha receptors.
*Indoramine*
- Indoramine is an **alpha-1 adrenergic receptor blocker** used historically for hypertension.
- It specifically **antagonizes alpha-1 receptors** in vascular smooth muscle, causing vasodilation.
*Idazoxan*
- Idazoxan is an **alpha-2 adrenergic receptor antagonist**, primarily used in research contexts.
- It **blocks presynaptic alpha-2 receptors**, which can lead to an increase in norepinephrine release.
*Prazosin*
- Prazosin is a well-known **alpha-1 adrenergic receptor blocker** used to treat hypertension and benign prostatic hyperplasia (BPH).
- It causes **vasodilation** by relaxing vascular smooth muscle, thus lowering blood pressure.
Adrenergic Antagonists Indian Medical PG Question 8: Mechanism of action of curare-like drugs?
- A. Blocks ACh receptors (Correct Answer)
- B. Agonistic with ACh receptors
- C. Inhibits ACh synthesis
- D. Causes persistent depolarization
Adrenergic Antagonists Explanation: ***Blocks ACh receptors***
- Curare-like drugs are **competitive antagonists** at the **nicotinic acetylcholine receptors (nAChRs)** found at the neuromuscular junction.
- By binding to these receptors, they prevent acetylcholine (ACh) from binding and activating the receptors, thereby **inhibiting muscle contraction**.
*Inhibits ACh synthesis*
- Drugs that inhibit ACh synthesis typically target enzymes like **choline acetyltransferase**.
- This mechanism would reduce the amount of ACh available, but curare acts directly at the *receptor level*.
*Causes persistent depolarization*
- This is the mechanism of action of **depolarizing neuromuscular blockers** like succinylcholine.
- They initially activate the receptor, causing a brief depolarization, followed by a sustained depolarization that renders the muscle unresponsive.
*Agonistic with ACh receptors*
- An agonist binds to and activates a receptor, mimicking the effect of the natural ligand (acetylcholine in this case).
- Curare-like drugs are **antagonists**; they bind to the receptor but do not activate it, instead blocking ACh binding.
Adrenergic Antagonists Indian Medical PG Question 9: Which sympathomimetic drug is primarily known to increase heart rate?
- A. Isoprenaline (Correct Answer)
- B. Phenylephrine
- C. Noradrenaline
- D. Adrenaline
Adrenergic Antagonists Explanation: ***Isoprenaline***
- **Isoprenaline** (isoproterenol) is a non-selective beta-adrenergic agonist, with a strong affinity for **β1 and β2 receptors** [1].
- Its activation of **β1 receptors** in the heart leads to a significant increase in **heart rate (positive chronotropy)** and contractility (positive inotropy) [1].
- It is the **most potent chronotropic agent** among sympathomimetics and is primarily known for increasing heart rate [2].
*Phenylephrine*
- **Phenylephrine** is a selective **α1 adrenergic agonist** that causes vasoconstriction [4].
- It increases blood pressure but typically causes **reflex bradycardia** (decreased heart rate) due to baroreceptor activation.
- Does NOT directly increase heart rate.
*Noradrenaline*
- **Noradrenaline** (norepinephrine) primarily acts on **α1 receptors** causing vasoconstriction, and to a lesser extent on **β1 receptors** [3].
- While it can stimulate β1 receptors, its predominant effect is to increase **mean arterial pressure** through vasoconstriction, often causing **reflex bradycardia** [3].
*Adrenaline*
- **Adrenaline** (epinephrine) acts on **α1, β1, and β2 receptors** [4]. While it does increase heart rate via **β1 receptor** stimulation, it also causes significant **vasoconstriction** (via α1) and **vasodilation** (via β2).
- Its cardiovascular effects are more complex and dose-dependent compared to isoprenaline's specific chronotropic action.
Adrenergic Antagonists Indian Medical PG Question 10: The drug that causes fall in elderly patients with postural hypotension is:-
- A. Acarbose
- B. Prazosin (Correct Answer)
- C. Nor-adrenaline
- D. Metformin
Adrenergic Antagonists Explanation: ***Prazosin***
- **Alpha-1 adrenergic blocker** used to treat hypertension and benign prostatic hyperplasia (BPH)
- Commonly causes **orthostatic hypotension (postural hypotension)** as a side effect by blocking alpha-1 receptors on vascular smooth muscle, preventing compensatory vasoconstriction upon standing
- Leads to **dizziness, lightheadedness, and falls**, especially in elderly patients who have reduced baroreceptor sensitivity
- **First-dose phenomenon** is particularly notable, with marked hypotension after the initial dose
*Acarbose*
- Alpha-glucosidase inhibitor used to treat type 2 diabetes by reducing carbohydrate absorption in the intestine
- Primary side effects are **gastrointestinal** (flatulence, diarrhea, abdominal discomfort)
- Does not affect blood pressure or cause postural hypotension
*Nor-adrenaline (Norepinephrine)*
- **Vasopressor** and sympathomimetic agent that causes vasoconstriction through alpha-adrenergic receptor stimulation
- **Increases blood pressure** and is used to treat severe hypotension in critical care settings
- Would not cause falls due to postural hypotension; rather, it counteracts hypotension
*Metformin*
- **Biguanide** oral hypoglycemic agent for type 2 diabetes that primarily decreases hepatic glucose production and increases insulin sensitivity
- Main side effects include gastrointestinal disturbances and rare lactic acidosis
- Not associated with postural hypotension or increased risk of falls
More Adrenergic Antagonists Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
